XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]        
Revenues    
Operating Expenses        
Research and development 3,605,898 4,726,855 $ 6,227,808 $ 8,172,370
General and administrative 4,285,911 4,792,850 7,946,639 7,396,137
Stock-based compensation – general and administrative 3,078,392 1,165,595 6,136,577 2,366,676
Total Operating Expenses 10,970,201 10,685,300 20,311,024 17,935,183
Operating Loss (10,970,201) (10,685,300) (20,311,024) (17,935,183)
Other Income        
Interest income 182,205 303,275 435,843 517,824
Gain on sale of New Jersey net operating losses 2,387,842   2,387,842 3,585,689
Total Other Income 2,570,047 303,275 2,823,685 4,103,513
Loss before Income Taxes (8,400,154) (10,382,025) (17,487,339) (13,831,670)
Income tax expense 144,000 144,000 288,000 288,000
Net Loss $ (8,544,154) $ (10,526,025) $ (17,775,339) $ (14,119,670)
Net Loss Per Share - Basic (in Dollars per share) $ (0.05) $ (0.07) $ (0.11) $ (0.1)
Weighted Average Common Shares Outstanding        
Weighted Average Common Shares Outstanding, Basic (in Shares) 159,072,239 146,251,945 159,013,769 146,231,313